Global Cataract Surgery Devices Market to See 3.9% Annual Growth, Bolstered by Rising Geriatric Population
September 08, 2022 08:33 ET
|
Research and Markets
Dublin, Sept. 08, 2022 (GLOBE NEWSWIRE) -- The "Cataract Surgery Devices Market By Product, By Type, By End User: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added...
Global Advanced Ophthalmology Technologies Market Report 2022: Technological Advancements in Ophthalmic Devices Presents Avenues for Growth
September 06, 2022 04:58 ET
|
Research and Markets
Dublin, Sept. 06, 2022 (GLOBE NEWSWIRE) -- The "Global Advanced Ophthalmology Technologies Market (2022-2027) by Type, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with...
Iantrek Raises $23M Series B Financing to Advance Next Generation Ophthalmic Micro-Interventional Technologies
August 30, 2022 08:00 ET
|
Iantrek, Inc.
WHITE PLAINS, N.Y., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Iantrek, Inc., a medical device company founded by ophthalmic innovator Dr. Sean Ianchulev, announced the closing of a $23M Series B financing....
Clearside Biomedical to Present at the Ophthalmology Futures Retina Forum 2022
August 25, 2022 07:05 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the...
Sight Sciences Introduces the SION™ Surgical Instrument – The First Bladeless Device Used in Goniotomy
August 23, 2022 08:03 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative solutions intended to...
OTC Artificial Tears Market Size is projected to reach USD 6.79 Billion by 2030, growing at a CAGR of 5.10%: Straits Research
August 18, 2022 10:30 ET
|
Straits Research
New York, United States, Aug. 18, 2022 (GLOBE NEWSWIRE) -- The application of artificial tears protects and hydrates mucous membranes and alleviates dryness and irritation of the eyes. Artificial...
Oyster Point Pharma Announces TYRVAYA® To Be Covered By the Largest Medicare Pharmacy Benefit Manager
August 17, 2022 08:00 ET
|
Oyster Point Pharma, Inc.
PRINCETON, N.J., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), (“Oyster Point Pharma”, or “the Company”), a commercial-stage biopharmaceutical company focused on the...
Sight Sciences Announces Long-Term Safety and Effectiveness Data of Standalone Use of the OMNI® Surgical System in Patients with Open Angle Glaucoma
August 16, 2022 08:01 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative solutions intended to...
Ocugen CEO to Present at H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference
August 12, 2022 07:30 ET
|
Ocugen
MALVERN, Pa., Aug. 12, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene...
Clearside Biomedical Announces Second Quarter 2022 Financial Results and Provides Corporate Update
August 09, 2022 07:05 ET
|
Clearside Biomedical, Inc.
- CLS-AX OASIS Phase 1/2a Trial Data from Cohorts 3 & 4 Expected in November 2022 - - Non-Dilutive Financing Agreement with HealthCare Royalty Supports Progression of CLS-AX Clinical Program - ...